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Abstract 
 
To test the hypothesis that the sulfotransferase gene plays a role in the phase II bioactivation of 
PhIP, a heterocyclic amine found in cooked meats, we transfected the UV5P3 cell line with 
cDNA plasmids of human aryl sulfotransferases (HAST1 and HAST3). UV5P3 is a nucleotide 
excision repairdeficient and P4501A2-expressing CHO cell line that we have previously 
developed. Functionally transformed clones were identified by the differential cytotoxicity (DC) 
assay that used PhIP as the cytotoxic agent. Two clones designated 5P3H1 and 5P3H3, 
expressing HAST1 and HAST3, respectively, were chosen for further characterization. Correct 
fragment sizes of the sulfotransferase cDNAs were identified in both cell lines by polymerase 
chain reaction. Immunoblot analysis confirmed the expression of the sulfotransferase pro teins. 
The addition of the sulfotransferase inhibitor DCNP decreased the cytotoxic effects of PhIP in a 
dose-dependent manner. The increase in cell growth was 6.5-fold for 5P3H1 and 2.4-fold for 
5P3H3, relative to values obtained without DCNP. Based on D50 values, the dose that reduced 
the survival to 50% relative to untreated controls, the cytotoxic effect of PhIP was increased 
threefold for 5P3H1 and 1.87-fold for 5P3H3 cell lines over the parental UV5P3 line. There was 
also a small increase in the mutation response at the aprt locus. These newly established 5P3H1 
and 5P3H3 sulfotransferase- expressing cells provide valuable mechanistic information of the 
bioactivation of PhIP and related compounds. 
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Introduction 
 
The mutagenic heterocyclic amine, 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP), is a pyrolysis 
product in cooked foods and is also the most mass-abundant heterocyclic amine in beef and chicken cooked well-
done [Felton et al., 1986; Sinha et al., 1995]. Studies have shown that PhIP causes mammary, colon, and prostate 
tumors in rats [Ito et al., 1991; Ghoshal et al., 1994; El-Bayoumy et al., 1995; Shirai et al., 1997], lymphomas in 
mice [Esumi et al., 1989], and hepatic adenomas in neonatal mice [Dooley et al., 1992]. PhIP has also been shown to 
induce DNA strand breaks, sister-chromatid exchanges, and to form DNA adducts in vitro and in vivo [Thompson et 
al., 1987; Buonarati et al., 1990b, 1991; Kaderlik et al., 1994; Fan et al., 1995; Ito et al., 1997]. Malfatti et al. [1999] 
have reported that PhIP is extensively metabolized in humans and that ;70% of PhIP and its metabolites can be 
recovered in the urine. Considering its ability to induce tumors in rodents, the substantial amount of absorption by 
humans, and its relative abundance in cooked meat, PhIP may pose a significant risk to human health. 
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The metabolism of PhIP involves both phase I and phase II pathways for bioactivation and/or detoxification. 
Bioactivation of PhIP is highly dependent on N-hydroxylation via cytochrome P4501A2 to the corresponding 
hydroxylamine [Buonarati et al., 1990a; Wallin et al., 1990]. In the phase II conjugation reaction, the N-
hydroxylated PhIP intermediate is converted by acetylation and/or sulfation to a highly reactive electrophilic species 
capable of covalently binding to DNA. In previous studies, we transfected the nucleotide excision repair-deficient 
CHO UV5 cells with cDNA of mouse P450 1A2 [Thompson et al., 1991], and human N-acetyltransferase cDNA 
[Wu et al., 1997]. This cell line 5P3NAT2 was extremely sensitive to the genotoxic effect of 2-amino-3-
methylimidazo[4,5,f]quinoline (IQ). However, the presence of the acetyltransferase gene did not have any 
significant effect on the cellular sensitivity or genotoxicity to PhIP. To test the hypothesis that sulfotransferase plays 
a role in the phase II metabolic activation pathway of PhIP, we transfected the CHO cells with sulfotransferase 
cDNAs. 
In this study we report the establishment of two new CHO lines 5P3H1 and 5P3H3. The 5P3H1 cell line expresses 
the mouse P4501A2 and a human aryl sulfotransferase HAST1 isolated from the human liver. The 5P3H3 cell line 
expresses the mouse P4501A2 and a human aryl sulfotransferase HAST3 isolated from the human brain. The 
UV5P3 cells that we previously established [Thompson et al., 1991] were used for the transfection of both 
sulfotransferase cDNAs. These newly established sulfotransferaseexpressing 5P3H1 and 5P3H3 cell lines can 
provide valuable information for determining the role of these enzymes in the metabolic activation of PhIP. 
 
Materials and Methods 
 
Chemicals 
 
Heterocyclic amines: 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), and 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (PhIP), were purchased from Toronto Research Chemicals (Downsview, Ontario, Canada). 2,6-Dichloro-
4-nitrophenol (DCNP) was obtained from Alfred Bader Library of rare chemicals, division of Aldrich Chemical Co. 
(Milwaukee, WI). 
 
Cells 
 
The CHO parental cell line AA8, which is heterozygous at the aprt locus [Thompson et al., 1980a], was used to 
derive the UV5 cell line [Thompson et al., 1980b], which lacks nucleotide excision repair due to a mutation in the 
XPD (ERCC2) gene [Weber et al., 1988]. Transfection of the UV5 cells with mouse P4501A2 cDNA established the 
UV5P3 line [Thompson et al., 1991]. The UV5P3 line was used for the transfection of human aryl sulfotransferase 
cDNAs of HAST1 and HAST3, and resulted in cell lines 5P3H1 and 5P3H3, respectively. HAST1 was isolated from 
a human liver cDNA library [Zhu et al., 1993a] and HAST3 from a human brain cDNA library [Zhu et al., 1993b]. 
All cells were grown in a-modified minimal essential medium supplemented as described in Weber et al. [1988]. 
 
Construction of Sulfotransferase Expression Plasmids 
 
The cDNA of HAST1 and HAST3 sulfotransferase were cloned into the EcoRI and XbaI restriction site of the 
mammalian expression plasmid pcDNA3 (Invitrogen, Carlsbad, CA). To generate the HAST1 plasmid, the pCMV5-
HAST1 plasmid [Veronese et al., 1994] was digested with EcoRI and XbaI to release the 1155-bp fragment of 
sulfotransferase cDNA. The excised gel-separated 1155-bp fragment was purified using QIAEXII gel extraction kit 
(Qiagen, Chatsworth, CA) and ligated into the similarly digested and dephosphorylated pcDNA3 vector. To generate 
the same restriction sites for cloning of HAST3, the pSL1180 Superlinker Phagemid (Pharmacia Biotech, 
Piscataway, NJ) was used. Briefly, the pCMV5-  HAST3 plasmid [Veronese et al., 1994] was digested with EcoRI 
and BamHI. The excised gel-separated 1200-bp cDNA was cloned into pSL1180 Superlinker Phagemid digested 
with the same restriction enzymes. The HAST3 2pSL1180 plasmid was next digested with EcoRI and XbaI, gel 
purified, and cloned into pcDNA3 plasmid. 
 
Transfection of UV5P3 and Selection of Transformed Cells  
 
Exponentially growing UV5P3 cells were transfected with pcDN3- HAST1 and pcDNA3-HAST3 plasmids by 
electroporation with a Cell- Porator Electroporation System following the protocol supplied by the manufacturer 
(Life Technologies, Rockville, MD). UV5P3 cells (1 3 107) were electroporated with 10 mg of plasmid DNA. The 
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transfected cells were plated at densities of 3 3 104 and 3 3 105 cells per 100-mm dish with 20 ml MEM-a and 
incubated for 24 hr. Media were then changed to MEM-a containing 1.6 mg/ml G-418 (Life Technologies) for 
selection of clones expressing the neo gene. G-418-resistant colonies arose at a frequency of 9.5 3 1024 and 9.6 3 
1024 for HAST1 and HAST3 transformants, respectively. Additionally, 900 transfected cells were inoculated into 
each well (containing 2 ml of complete media with G-418) of the 24-well cluster trays for isolation of independent 
clones, thus ensuring genetic homogeneity. The cells were incubated at 37°C for 10 days, and wells that contained 
single colonies were identified under the microscope. The isolated colonies were removed and transferred to larger 
culture vessels for expansion. They were screened using PhIP and IQ by the differential cytotoxicity (DC) assay 
similar to our previous study [Wu et al., 1997]. PhIP at concentrations from 0.01 to 1.0 mg/ml and IQ from 0.3 to 30 
mg/ml were used for the DC assay. 
 
Inhibitor Study 
 
2,6-Dichloro-4-nitrophenol (DCNP) was used in the inhibition studies of 5P3H1 and 5P3H3 cell lines. Both DCNP 
(0.05 mM, 0.075 mM, and 0.1 mM) and PhIP (0.1, 0.3, 0.5, 0.7, and 1.0 mg/ml) were added to these cells. After 
incubation at 37°C for 72 hr, the cells were fixed and stained with crystal violet. The intensity of the stain in each 
well indicated cell growth and was analyzed by digital scanning, according to a protocol supplied by Kodak 1D 
2.0.2. To ensure that DCNP by itself (without PhIP) did not have any cytotoxic effect on the sulfotransferase cells, 
mutagenesis experiments were performed at concentrations of 0.05, 0.075, 0.1, and 0.12 mM of DCNP. 
 
PCR Amplification 
 
Genomic DNA from UV5P3, 5P3H1, and 5P3H3 cells was isolated by a salting-out procedure used in our previous 
study [Wu et al., 1995]. The sulfotransferase gene was amplified by PCR using the following primers: 22-mer 
oligonucleotide forward primer (59-CATGGAGCT GATCCAGGACACC- 39) and 20-mer oligonucleotide reverse 
primer (59-AGCCCCTC TCACAGCTCAGA-39) flanking the coding sequence of the sulfotransferase gene. These 
primers were synthesized by Genset (La Jolla, CA). This set of primers was used for amplifying the sulfotransferase 
genes in both 5P3H1 and 5P3H3 cells. PCR reactions (100 ml) contained 1 mM of each primer; 1 mg of template; 
50 mM KCl; 10 mM Tris–HCl, pH 8.3; 1.5 mM MgCl2; 0.2 mM dNTP; and Tag polymerase at 2 units/reaction. 
Reactions were cycled 35 times with 2 min denaturing at 94°C, 1 min annealing at 69°C, and 2 min extension at 
72°C (7 min in the last cycle). 
 
Gel Electrophoresis and Immunoblotting 
 
Immunoblot analysis was used to confirm the expression of the sulfotransferase protein by the inserted cDNA. 
UV5P3, 5P3H1, and 5P3H3 cells were harvested by centrifugation at 1000g for 5 min and resuspended in 100 mM 
Tris buffer (pH 7.5). The harvested cells were lysed by three cycles of freezing and thawing. Suspensions were 
centrifuged at 9000g for 10 min, the supernatant collected, and this fraction was centrifuged at 100,000g for 1 hr. 
The supernatant, designated cytosol, was aspirated and immediately frozen at 280°C. The cytosol fractions were 
analyzed by 10% SDS–polyacrylamide gel electrophoresis according to the method of Laemmli et al. [1970]. 
Protein bands were transferred electrophoretically to a nitrocellulose membrane according to the protocol supplied 
by the Mini Trans-Blot cell system from Bio-Rad (Hercules, CA). Nonspecific binding sites on the membrane were 
blocked by incubation in a solution of 5% (w/v) dry milk, 0.2% Tween 20, and TBS (pH 7.5) for 2 hr at 37°C. 
Primary antihuman sulfotransferase (HAST1) antibodies raised in goats at a 1:200 dilution were added to the same 
solution and incubated overnight at 4°C. The blot was washed at three 5-min intervals before adding a secondary 
horseradish peroxidase–linked antigoat antibody (Santa Cruz Biotechnology, Inc.) at a dilution of 1:10,000, and 
incubated for 1 hr at room temperature. The blot was then washed three times. Rainbow markers from Amersham 
Life Science (Arlington Heights, IL) were used as size standards. Enhanced chemiluminescent detection system was 
employed to reveal antigen–antibody interactions and was performed as described by the manufacturer ECL 
(Amersham Life Science). 
Environmental and Molecular Mutagenesis (2000) 35 (1): 57-65.  doi: 10.1002/(SICI)1098-
2280(2000)35:1<57::AID-EM8>3.0.CO;2-7   
 
Cell Survival and Mutation at the aprt Locus 
 
Exponentially growing cells were exposed to either PhIP or IQ and plated for cell survival determination and 
mutation frequency at the aprt locus as described previously [Wu et al., 1997]. The only exception was that 2 3 105 
cells of 5P3H3 and 6 3 105 cells of 5P3H1 were plated onto 8-azaadenine dishes for the mutation studies. PhIP and 
IQ dissolved in DMSO were added in concentrations ranging from 0.025 to 0.25 mg/ml and 5.0 to 65.0 mg/ml, 
respectively. Control samples containing only media and DMSO were also included. 
 
Results 
 
Identification of HAST1 or HAST2 Sulfotransferase Transformants of UV5P3 Cells  
 
G-418 resistant clones from the 24-well-cluster trays of both cell lines were isolated and expanded for analysis. 
Expression of the sulfotransferase cDNA was inferred using the differential cytotoxicity assay by the sensitivity of 
the clonal isolates to PhIP. Four out of eight HAST1 and two out of nine HAST3 transformants showed sensitivity 
to PhIP beginning at 0.3 mg/ml, whereas the parental line (UV5P3) showed sensitivity to PhIP at 0.5 mg/ml (Fig. 1, 
upper). In contrast, when these transformants were exposed to IQ, they showed no cytotoxicity up to 30 mg/ml and 
were similar to the parental line UV5P3 (Fig. 1, lower). One HAST1 transformant (5P3H1 cell line) and one HAST3 
transformant (5P3H3 cell line) were used for further studies. 
 
Inhibition Study 
 
DCNP is a potent selective inhibitor for human phenol sulfotransferases [Rein et al., 1982; Veronese et al., 1994; 
Chou et al., 1995a,b]. The inhibition of sulfotransferase activity by DCNP was monitored by a decrease in the 
cytotoxic effect of PhIP, which results in an increase in cell growth (Fig. 2A, 2B). DCNP showed a dose-dependent 
response with these new cell lines. Exposure of cells to 0.1 mM DCNP and 1.0 mg/ml PhIP over a period of 72 hr 
caused an increase in cell growth of 6.5-fold for 5P3H1 and 2.4-fold for 5P3H3, relative to values obtained without 
DCNP. These data indicated that the 5P3H1 cell line was more sensitive to the cytotoxic effect of PhIP, hence more 
sensitive to DCNP inhibition than the 5P3H3 cell line. Results that demonstrate HAST1 is more sensitive to DCNP 
inhibition than HAST3 have also been reported by others [Rein et al., 1982; Veronese et al., 1994; Weinshilboum et 
al., 1994; Chou et al., 1995a,b]. By itself, DCNP was neither cytotoxic nor mutagenic at the dose range tested 0.05 
to 0.12 mM (data not shown). The effectiveness of DCNP inhibition on these cell lines indicates that the 
sulfotransferase cDNAs are functionally expressed. 
 
PCR Amplification Reaction 
 
Amplification of the sulfotransferase cDNAs from both 5P3H1 and 5P3H3 were carried out using the same set of 
primers and under the same PCR conditions. The coding domain of the sulfotransferase in these two cell lines 
showed 93% homology [Veronese et al., 1994; Bidwell et al., 1998]. The 897-bp PCR-amplified product of the 
sulfotransferase gene from the genomic DNA of both cell lines is shown in Figure 3. This fragment was absent in 
the parental line UV5P3. 
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Detection of Sulfotransferase Protein by Immunoblotting  
 
Immunoblot analysis confirmed the presence of the sulfotransferase protein in the cytosol fraction of 5P3H1 and 
5P3H3 cells (Fig. 4). Probing for both cell lines was performed using antihuman sulfotransferase HAST1 antibodies 
raised in goats, because HAST1 and HAST3 are structurally closely related [Falany et al., 1990]. Immunoreactive 
polypeptides of molecular mass 32 kDa for 5P3H1 and 34 kDa for 5P3H3 cells were detected using a 
chemiluminescent detection system. This is in agreement with the sizes reported by others [Jones et al., 1993; 
Veronese et al., 1994]. No signal was detected in the parental line UV5P3. 
 
Cell Killing and Mutagenesis Mediated by Metabolism of PhIP and IQ  
 
The sensitivity of the 5P3H1 and 5P3H3 cells to PhIP was evaluated by cell killing (Fig. 5A) and mutation at the 
aprt locus determined by resistance to 8-azaadenine (Fig. 5B). These cell lines exhibited cell killing over the entire 
range of PhIP concentrations tested (0.025– 0.25 mg/ml). Based on D50 values, the cytotoxic effect of PhIP was 
increased threefold for 5P3H1 and 1.9-fold for 5P3H3 lines compared to the parental UV5P3 cell line. There was 
also an increase in the mutation response at the aprt locus with a peak at 0.1 mg/ml for both cell lines. Mutation 
frequencies seemed to decline at the higher doses in both lines, suggesting the preferential conversion of damage to 
lethal lesions. An elevated spontaneous frequency in both cell lines was also observed. The average values for five 
experiments to determine the spontaneous mutation frequency for 5P3H1 and 5P3H3 were 26 6 1.8 3 1025 and 175 
6 20.8 3 1025, respectively. In our previous study [Thompson et al., 1991], we found that the highest mutation 
frequency in the UV5P3 cells occurred at 0.5 mg/ml of PhIP. When compared to the dose (0.1 mg/ml) producing 
highest mutation frequency in the sulfotransferase expressing cell lines (Fig. 5B), this was a fivefold dose increase in 
sensitivity. The experiments performed with IQ were done over a somewhat different dose range (5–65 mg/ml). The 
survival curves for both 5P3H1 and 5P3H3 were unusual because of their shallow slopes, and cell killing did not 
increase rapidly with increasing dose (Fig. 6A). No detectable increase in mutation frequency was observed (Fig. 
6B). From our previous study [Wu et al., 1997], the initial slope of the survival curve for the UV5P3 line was 
shallow but dropped rapidly after 10 mg/ml of IQ, and no detectable increase in mutation frequency was observed 
over the entire dose range (Fig. 6A, 6B). This rapid dropped in cell survival also corresponded to the decrease in 
mutant frequency. This may be due to the preferential conversion of damage to lethal lesions in these cells. 
 
Environmental and Molecular Mutagenesis (2000) 35 (1): 57-65.  doi: 10.1002/(SICI)1098-
2280(2000)35:1<57::AID-EM8>3.0.CO;2-7   
 
 
Environmental and Molecular Mutagenesis (2000) 35 (1): 57-65.  doi: 10.1002/(SICI)1098-
2280(2000)35:1<57::AID-EM8>3.0.CO;2-7   
 
 
Environmental and Molecular Mutagenesis (2000) 35 (1): 57-65.  doi: 10.1002/(SICI)1098-
2280(2000)35:1<57::AID-EM8>3.0.CO;2-7   
  
 
Discussion 
 
In this study, we introduced the human HAST1 or HAST3 sulfotransferase cDNA into the repair-deficient, 
P4501A2-expressing UV5P3 cells. The presence of the sulfotransferase cDNAs within these cells was confirmed by 
PCR, and protein expression was confirmed by Western blot analysis. These new lines, 5P3H1 and 5P3H3, were 
used to evaluate the genotoxicity of heterocyclic amines, PhIP and IQ. These compounds were first activated by 
cytochrome P4501A2 [McManus et al., 1990; Thompson et al., 1991; Guengerich et al., 1992]. The resultant N-
hydroxy intermediates underwent subsequent sulfation provided by the sulfotransferase expressing cell lines. Our 
study showed that both new lines are more sensitive to the cytotoxic effect of PhIP than the parental UV5P3 
expressing only P4501A2. The addition of the sulfotransferase inhibitor DCNP decreased the cytotoxic effect of 
PhIP in a dose-dependent manner. Additionally, our data indicated that 5P3H1 cells are more sensitive to the 
cytotoxic effect of PhIP than the 5P3H3 cells. This may be due to the substrate specificity of these different aryl 
sulfotransferases. Veronese et al. [1994] reported that the preferred substrate for HAST1 was pnitrophenol, whereas 
the preferred substrate for HAST3 was dopamine. However, HAST3 could metabolize p-nitrophenol but with two 
orders of magnitude lower affinity [Veronese et al., 1994]. The data from the DCNP inhibition and D50 cell-survival 
experiments indicate that PhIP is the preferred substrate for HAST1 in the 5P3H1 cells. Our present study shows 
that the sulfotransferases (STs) play a role in the bioactivation of PhIP. 
On the other hand, the cytotoxic and mutagenic effects of IQ were negligible with these newly established 
lines, 5P3H1 and 5P3H3. Other investigators [Abu-Zeid et al., 1992; Chou et al., 1995a] have also reported that no 
sulfotransferase- mediated DNA binding of N-hydroxy-IQ has been detected. However, the 5P3NAT2 cell line 
expressing N-acetyltransferase, established from our previous investigation, was extremely sensitive to the cytotoxic 
as well as mutagenic effect of IQ [Wu et al., 1997]. We concluded that the acetyltransferase gene plays an important 
role in the phase II bioactivation of IQ. On the other hand, the presence of the sulfotransferase gene does not have 
any significant effect on the cellular sensitivity to IQ as is shown by our present study.  
Exposure to PhIP resulted in a small increase of mutation frequency in 5P3H1 and 5P3H3 cells (Fig. 5B). 
Due to the relatively high spontaneous mutant frequency, the sensitivity of detecting mutants was greatly reduced. 
All experiments were done with clonal stocks frozen immediately after expansion to mass culture, thus minimizing 
the accumulation of mutations. The actual cause of this high spontaneous mutant frequency is not clear. It is possible 
that transfection itself in some unknown manner may have elevated the spontaneous mutant frequency. The 
availability of 39-phosphoadenosine-59-phosphosulfate (PAPS) in these CHO cells is not known. PAPS is an 
absolute requirement for the activation of the sulfotransferase reaction [Chou et al., 1995a]. There is a possibility 
that the limited amount of PAPS present in the CHO cells can impede the bioactivation of N-hydroxy PhIP, thus 
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affecting the mutation frequency. We will be investigating the role of PAPS in these cells in the future. Another 
explanation for the marginal increase in the mutation frequency (Fig. 5B) may be due to the instability of the N-
sulfonyloxy esters. The sulfoconjugated reactive intermediates may undergo rapid rearrangement to their 
corresponding phenolic sulfates and become detoxified [Ozawa et al., 1998]. Due to the complexicity of PhIP 
metabolic pathways [Malfatti et al., 1999] and various unknown factors within these cells, this small increase in the 
mutant frequency may be significant.  
 
  
 
Various human and rat STs have been successfully ex pressed in E. coli [Bidwell et al., 1998; Coughtrie et 
al., 1998] and in Salmonella typhimurium [Glatt et al., 1995]. In the mammalian system, STs have been transiently 
expressed in COS cells [Coughtrie et al., 1998], and stably expressed in Chinese hamster V79 cells [Czich et al., 
1994; Glatt et al., 1998]. The expression of STs in bacteria and mammalian cells has facilitated the study of their 
substrate specificities, protein structure, and function relationships, and has led to the detection of genotoxic effects 
with many chemical compounds. Benzylic alcohols derived from polycyclic aromatic hydrocarbons have been 
evaluated extensively by these recombinant sulfotransferase bacteria and V79 cells [Czich et al., 1994; Glatt et al., 
1998]. One line, V79-MZ-rCYP1A2, expressing both rat cytochrome P4501A2 [Wo¨lfel et al., 1991] and a male-
specific rat sul- fotransferase [Nagata et al., 1993], was used to evaluate the cytotoxicity and mutagenicity of 2-
acetylaminofluorene at the hprt locus [Glatt et al., 1998]. The present study is the first to stably express the HAST1 
and HAST3 sulfotransferases in the repair deficient CHO cell line. 
Many investigators have reported that metabolic activation of N-hydroxy PhIP by sulfation can generate 
reactive ester derivatives that covalently modify DNA [Ozawa et al., 1994; Chou et al., 1995a]. The formation of 
such DNA adducts can lead to mutations, which in turn can trigger the initiation of the carcinogenic process [Schut 
et al., 1999]. Studies by others [Cappiello et al., 1990; Pacifici et al., 1994] have shown the presence of various 
sulfotransferases in the human gastrointestinal tract. In light of this fact, it is reasonable to assume the production of 
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highly reactive ester derivatives from the bioactivation of dietery procarcinogens, such as PhIP, within the 
gastrointestinal tract. Indeed, PhIP-DNA adducts have been detected in the colons of humans given dietary 
equivalent levels of PhIP labeled with 14C [Dingley et al., 1999] by using accelerator mass spectrometry [Turteltaub 
et al., 1990, 1995]. Colorectal cancer has been implicated from dietary heterocyclic aromatic amines [Lang et al., 
1994]. Studies by others [Burchell et al., 1997; Ozawa et al., 1998] have indicated that the expression of 
sulfotransferases appear to be polymorphic within the human population. This genetic polymorphism can play an 
important role in determining an individual’s susceptibility to dietary mutagens/carcinogens such as PhIP. In light of 
the proposed role played by PhIP in the etiology of human colorectal cancer, we examined the role of two human 
sulfotransferases, HAST1 and HAST3. The newly established CHO cell lines 5P3H1 and 5P3H3 indicate that these 
sulfotransferases play a role in the bioactivation of PhIP. It is quite possible that sulfotransferases make up only one 
of a number of phase II pathways responsible for activating PhIP. 
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